Paul Dobesh, PharmD, Points Out the Benefits of Combining Anticoagulant and Antiplatelet Treatments

Dr. Dobesh addresses the challenges of achieving efficacy without having the patient bleed when combining anticoagulant and antiplatelet treatments.

Related Videos

Related Content

Advertisement

June 12th 2024

Barriers to DMD Care Access and How Policy Change Can Support Patients: Dr Migvis Monduy

Rose McNulty Hayden E. Klein

Migvis Monduy, MD, medical director of Neuromuscular and Movement Disorders Programs at Nicklaus Children's Hospital, discussed challenges in Duchenne muscular dystrophy (DMD) treatment access and how policy changes may support patients with DMD.

June 11th 2024

Fighting for the Future of LGBTQ Pride at Rutgers

Maggie L. Shaw

Continuing with our Pride Month podcast series, in this episode we speak with Perry Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, and James F. Dougherty, MS, VMD, current member of Rutgers' Board of Governors.

June 10th 2024

Dr Amit Singal on the Improving Outlook for HCC and How to Choose Treatments

Rose McNulty

Amit Singal, MD, medical director of the Liver Tumor Program at UT Southwestern Medical Center, discussed the current outlook for patients with hepatocellular carcinoma (HCC) and how to choose between therapies.

June 3rd 2024

Celebrating Pride Month With Lancaster Pride

Maggie L. Shaw

For June and Pride Month, we are bringing you our newest limited-edition podcast series. In this first episode, we speak with Lancaster, Pennsylvania, native and president of Lancaster Pride, Tiffany Shirley.

June 6th 2024

Dr Allison Brager Highlights the Influence of Sleep on Cardiovascular Health

Pearl Steinzor

Allison Brager, PhD, neuroscientist, Walter Reed Army Institute of Research, discusses the interplay between physical exercise and circadian rhythms in improving cardiovascular health.

June 4th 2024

Dr Juneko Grilley-Olson Discusses New Findings, Future Directions for Alliance A091902 Trial in Angiosarcoma

Maggie L. Shaw Sabrina Serani

The Alliance A091902 trial is currently investigating paclitaxel with and without nivolumab in patients who are taxane naive and nivolumab plus cabozantinib in taxane-pretreated patients.

Related Content

Advertisement

June 12th 2024

Barriers to DMD Care Access and How Policy Change Can Support Patients: Dr Migvis Monduy

Rose McNulty Hayden E. Klein

Migvis Monduy, MD, medical director of Neuromuscular and Movement Disorders Programs at Nicklaus Children's Hospital, discussed challenges in Duchenne muscular dystrophy (DMD) treatment access and how policy changes may support patients with DMD.

June 11th 2024

Fighting for the Future of LGBTQ Pride at Rutgers

Maggie L. Shaw

Continuing with our Pride Month podcast series, in this episode we speak with Perry Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, and James F. Dougherty, MS, VMD, current member of Rutgers' Board of Governors.

June 10th 2024

Dr Amit Singal on the Improving Outlook for HCC and How to Choose Treatments

Rose McNulty

Amit Singal, MD, medical director of the Liver Tumor Program at UT Southwestern Medical Center, discussed the current outlook for patients with hepatocellular carcinoma (HCC) and how to choose between therapies.

June 3rd 2024

Celebrating Pride Month With Lancaster Pride

Maggie L. Shaw

For June and Pride Month, we are bringing you our newest limited-edition podcast series. In this first episode, we speak with Lancaster, Pennsylvania, native and president of Lancaster Pride, Tiffany Shirley.

June 6th 2024

Dr Allison Brager Highlights the Influence of Sleep on Cardiovascular Health

Pearl Steinzor

Allison Brager, PhD, neuroscientist, Walter Reed Army Institute of Research, discusses the interplay between physical exercise and circadian rhythms in improving cardiovascular health.

June 4th 2024

Dr Juneko Grilley-Olson Discusses New Findings, Future Directions for Alliance A091902 Trial in Angiosarcoma

Maggie L. Shaw Sabrina Serani

The Alliance A091902 trial is currently investigating paclitaxel with and without nivolumab in patients who are taxane naive and nivolumab plus cabozantinib in taxane-pretreated patients.